Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
R Spiegel, A Enz, AE Veroff, NR Cutler - Journal of Neural Transmission, 2002 - Springer
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
E Giacobini, R Spiegel, A Enz… - Journal of neural …, 2002 - pubmed.ncbi.nlm.nih.gov
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimers disease by rivastigmine: correlation with cognitive benefit
E Giacobini, R Spiegel, A Enz, AE Veroff… - Journal of Neural …, 2002 - infona.pl
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimers disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimers disease (AD) to date. This multiple-dose study has examined the relationship …
[引用][C] Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
E GIACOBINI, R SPIEGEL, A ENZ… - Journal of neural …, 2002 - pascal-francis.inist.fr
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with
Alzheimer's disease by rivastigmine: correlation with cognitive benefit CNRS Inist Pascal-Francis …
Alzheimer's disease by rivastigmine: correlation with cognitive benefit CNRS Inist Pascal-Francis …
[引用][C] Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
E Giacobini, R Spiegel, A Enz, AE Veroff… - Journal of Neural …, 2002 - cir.nii.ac.jp
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with
Alzheimer's disease by rivastigmine: correlation with cognitive benefit | CiNii Research CiNii …
Alzheimer's disease by rivastigmine: correlation with cognitive benefit | CiNii Research CiNii …
[PDF][PDF] Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
E Giacobini, R Spiegel, A Enz, AE Veroff… - J Neural …, 2002 - researchgate.net
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
E Giacobini, R Spiegel, A Enz, AE Veroff… - Journal of Neural …, 2002 - elibrary.ru
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
E Giacobini, R Spiegel, A Enz, AE Veroff… - Journal of Neural …, 2002 - europepmc.org
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
E Giacobini, R Spiegel, A Enz… - Journal of Neural …, 2002 - search.ebscohost.com
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
E Giacobini, R Spiegel, A Enz… - Journal of Neural …, 2002 - search.ebscohost.com
Cholinesterase (ChE) inhibition represents the most efficacious treatment approach for
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …
Alzheimer's disease (AD) to date. This multiple-dose study has examined the relationship …